Beactica`s TEAD programme selected for late-breaking research presentation
14 Feb 2024 //
PR NEWSWIRE
Beactica Therapeutics to present breakthrough in YAP-TEAD programme
16 May 2023 //
PR NEWSWIRE
Beactica to present update on LSD1 programme at the AACR Annual Meeting 2023
11 Apr 2023 //
PR NEWSWIRE
Beactica and Oscotec mutually agree to conclude oncology collaboration
04 Apr 2023 //
PR NEWSWIRE
Beactica receives FDA Orphan Drug Designation for BEA-17 for glioblastoma
01 Feb 2023 //
PR NEWSWIRE
Dong-A ST and Beactica mutually agree to conclude oncology collaboration
06 Sep 2022 //
PRNEWSWIRE
Oscotec and Beactica Therapeutics announce license and collaboration agreement
02 Mar 2021 //
PRNEWSWIRE
Oscotec and Beactica announce license and collaboration
01 Mar 2021 //
PRNEWSWIRE
Dong-A ST with Beactica to develop new cancer treatments
03 Dec 2019 //
BIOSPECTRUM ASIA